INS and type 1 diabetes mellitus: Removing insulin from people with atypical type 1 diabetes (negative autoantibodies) comes with a great risk of ketoacidosis, so careful intervention in a hospital setting is critical when assessing variant carriers and treatment response in paediatric patients.